We found that pimozide inhibits the tyrosine phosphorylation of STAT5 in CML cells, raising the possibility that it may be a BCR/ABL inhibitor. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.